Home
Search
Study Topics
Glossary
|
|
|
|
|
Tracking Information | |||||
---|---|---|---|---|---|
First Received Date † | April 18, 2001 | ||||
Last Updated Date | November 3, 2005 | ||||
Start Date † | February 1997 | ||||
Current Primary Outcome Measures † |
|
||||
Original Primary Outcome Measures † | Same as current | ||||
Change History | Complete list of historical versions of study NCT00015249 on ClinicalTrials.gov Archive Site | ||||
Current Secondary Outcome Measures † | |||||
Original Secondary Outcome Measures † | |||||
Descriptive Information | |||||
Brief Title † | Prepulse Inhibition of Startle in Cocaine Dependence - 7 | ||||
Official Title † | Prepulse Inhibition of Startle in Cocaine Dependence (Human) | ||||
Brief Summary | The purpose of this study is to assess the effects of chronic cocaine use on the acoustic startle response and on gating of this response in humans. |
||||
Detailed Description | The objective of this study is to assess the effects of chronic cocaine use on the acoustic startle response and on gating of this response in humans. |
||||
Study Phase | Phase I | ||||
Study Type † | Interventional | ||||
Study Design † | Diagnostic, Double-Blind, Placebo Control | ||||
Condition † |
|
||||
Intervention † | Drug: Amantadine | ||||
Study Arms / Comparison Groups | |||||
Publications * | |||||
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status † | Completed | ||||
Enrollment † | 0 | ||||
Completion Date | |||||
Primary Completion Date | |||||
Eligibility Criteria † | Inclusion Criteria: Cocaine dependence. Male. Right handed. Negative urine for cocaine Exclusion Criteria: Positive urine for cocaine. History of head trauma. Significant medical disease. |
||||
Gender | Male | ||||
Ages | 18 Years to 60 Years | ||||
Accepts Healthy Volunteers | No | ||||
Contacts †† | |||||
Location Countries † | United States | ||||
Expanded Access Status | |||||
Administrative Information | |||||
NCT ID † | NCT00015249 | ||||
Responsible Party | |||||
Secondary IDs †† | Y01-5-0013-7 | ||||
Study Sponsor † | National Institute on Drug Abuse (NIDA) | ||||
Collaborators †† | New York MDRU | ||||
Investigators † |
|
||||
Information Provided By | National Institute on Drug Abuse (NIDA) | ||||
Verification Date | June 1998 | ||||
† Required WHO trial registration data element. †† WHO trial registration data element that is required only if it exists. |